AUSTRALASIA
A rush to register COVID-19 related trade marks
The COVID-19 pandemic has led to numerous companies seeking to register COVID-19 related trade marks in relation to a wide range of goods and services in many countries throughout the world. In...
The COVID-19 pandemic has led to numerous companies seeking to register COVID-19 related trade marks in relation to a wide...
Read More
SOUTHEAST ASIA
Singapore Patent Fast Track Programme
The Intellectual Property Office of Singapore (IPOS) has launched a new fast-track programme (named “SG Patent Fast Track”) to accelerate the patent application-to-grant process in Singapore. The programme is...
The Intellectual Property Office of Singapore (IPOS) has launched a new fast-track programme (named “SG Patent Fast Track”) to...
Read More
AUSTRALASIA
Terminating and re-negotiating your contracts under COVID-19
The COVID-19 pandemic has substantially disrupted the operation of the Australian society and overseas. Supply chains are interrupted due to travel restrictions, the mode of business operation has changed overnight as a...
The COVID-19 pandemic has substantially disrupted the operation of the Australian society and overseas. Supply chains are interrupted due to travel...
Read More
AUSTRALASIA
Australian Federal Court Decision – VAGISIL v VAGISAN
Dr August Wolff GmbH & Co. KG Arzneimittel v Combe International Ltd FCA 39 (3 February 2020) On 3 February 2020, Dr August Wolff GmbH & Co. KG Arzneimittel...
Dr August Wolff GmbH & Co. KG Arzneimittel v Combe International Ltd FCA 39 (3 February 2020) On 3...
Read More
AUSTRALASIA
TGA transparency reforms (part 1): Notification of generic and biosimilar medicines to impact pharmaceutical patent disputes in Australia
Regulatory changes recently approved by the Australian Government are likely to impact the way in which pharmaceutical patent litigation is conducted in Australia. The Therapeutic Goods Administration (TGA) is...
Regulatory changes recently approved by the Australian Government are likely to impact the way in which pharmaceutical patent litigation...
Read More
AUSTRALASIA
Bad Faith in Australia – A Brief Review of Recent Cases
The relatively new “bad faith” (section 62A) ground of opposition can be a strong basis for action against misappropriation of a trade mark owners’ goodwill, where the more commonly...
The relatively new “bad faith” (section 62A) ground of opposition can be a strong basis for action against misappropriation...
Read More
AUSTRALASIA
Electronic witnessing of documents under Covid-19
Further to our earlier article on the subject of electronic signatures,  New South Wales is the first state in Australia to enable the electronic witnessing of documents in response...
Further to our earlier article on the subject of electronic signatures,  New South Wales is the first state in...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe